Results 231 to 240 of about 13,137 (323)

Lymphadenopathy in Concurrent Head and Neck Malignancies

open access: yesCase Reports in Radiology, Volume 2026, Issue 1, 2026.
Second primary malignancies in the head and neck are a major cause of morbidity and mortality and include mucosal epithelial, hematologic, and cutaneous malignancies. Much is known about the imaging features of metastatic cervical lymphadenopathy in a single disease process; however, information on the imaging evaluation of cervical lymph nodes in the ...
Timothy Fitzgerald   +2 more
wiley   +1 more source

Ocular Melanoma: A Comprehensive Review with a Focus on Molecular Biology. [PDF]

open access: yesInt J Mol Sci
Iavarone L   +8 more
europepmc   +1 more source

Application of Local Hyperthermia Therapy Based on Immune Cell Function in Cutaneous Infectious Diseases

open access: yesDermatologic Therapy, Volume 2026, Issue 1, 2026.
Hyperthermia represents a physiological state marked by an elevation in body temperature due to the malfunctioning of thermoregulatory mechanisms. It transpires when the body either generates or absorbs a greater amount of heat than it is capable of expelling.
Zhiya Yang   +5 more
wiley   +1 more source

Marcus-Gunn Jaw-Winking Phenomenon: A Case Report on Rare Oculofacial Synkinesis. [PDF]

open access: yesInt Med Case Rep J
Alharthe AFH   +3 more
europepmc   +1 more source

Medium‐Term Study Results of Ultrasound‐Guided Radiofrequency Ablation for Thyroid Follicular Neoplasm With Low SUV in PET/CT

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background This study aimed to evaluate the medium‐term outcomes of radiofrequency ablation (RFA) for thyroid nodules with cytology of follicular neoplasm and low standard uptake value (SUV) in a positron emission tomography (PET/CT) study. Methods Between January 2018 and January 2021, 40 patients diagnosed with follicular neoplasm underwent ...
An-Ni Lin   +8 more
wiley   +1 more source

Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety

open access: yesInternational Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Thyroid eye disease (TED) is an autoimmune inflammatory condition linked to thyroid dysfunction, which can result in disfigurement and potential vision loss. Recently, immunomodulatory therapies such as rituximab have demonstrated potential benefit in managing TED.
Ming Lu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy